The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIofina Regulatory News (IOF)

Share Price Information for Iofina (IOF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 19.50
Bid: 19.00
Ask: 20.00
Change: -0.50 (-2.50%)
Spread: 1.00 (5.263%)
Open: 19.50
High: 20.00
Low: 19.50
Prev. Close: 20.00
IOF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Operational Update

7 Mar 2013 07:00

RNS Number : 4293Z
Iofina PLC
07 March 2013
 



 

 

7 March 2013

 

 

Iofina plc

("Iofina" or the "Group")

(LSE AIM: IOF)

 

Operations Update

 

Iofina, a specialist in the exploration and production of iodine and specialty chemical iodine derivatives, is pleased to announce to shareholders today an Operations Update.

 

 

HIGHLIGHTS:

 

·; IOsorb™ iodine production process proving successful, with 80-95% recovery of iodine contained in iodine rich brine streams;

·; Production at IO#2 plant is in line with expectations and further optimisation is planned;

·; Delivery of IO#3 expected into the US by the end of March;

·; IO#1 and IO#2 are expected to be producing cumulatively over 300 metric tonnes per year

·; Updates on Iofina Chemical and the Atlantis Water Project will be contained in the upcoming year-end trading report

 

WET® IOsorb™ IO#1 ("IO#1") and IO#2 ("IO#2") plants, which are located within the Group's Southwest Operations Group, started production late in the third quarter 2012 and early first quarter 2013 respectively. These initial two plants have already proved that the Group's proprietary iodine production model is a successful process with iodine yield efficiency in the range of 80-95 per cent, with ultimate recovery dependent on brine temperature and iodine part per million contained in each specific brine stream.

 

As previously announced in December 2012, IO#1 was initially limited by both a shortfall of brine, owing to trucking and disposal sites, and issues as to iodine content within the brine. The major independent oil and gas operator has subsequently increased the current average daily brine volume along with iodine content to this location. Iofina created a robust sampling program of the individual wells which translates into a geologic model for the area. Some wells in the area contained marginal iodine content and others are circa 200ppm. The Group now has a better understanding of the well completion techniques that cause this variance and will incorporate this knowledge into its business development strategy for the Company going forward on new sites. Further optimisation of the brine volume and iodine contained in the brine will continue at IO#1 with the goal of obtaining maximum capacity while increasing the overall iodine contained in the brine along with warmer temperatures.

 

IO#2, which, in contrast to IO#1, receives its brine input directly from the producing wells, enjoys far greater certainty as to iodine concentration and higher brine temperatures, which are greater than 40 degrees Celsius. The optimal water temperature helps yield improved efficiency for volume throughput which is now averaging in the low 90 per cent range on extraction efficiency. Initial throughput has been in line with expectations and will continue to increase over the next few weeks. Further wells will be tied in on a regular basis when wells are drilled and completed. IO#2 is performing in line with expectations and further fine tuning will continue to take place over the next 90 days in order to incorporate all the operational improvements learned from IO#1. As things currently stand we expect IO#1 and IO#2 to be producing circa 300 metric tonnes per year cumulatively.

 

As a result of the experience gained from IO#1 and IO#2 to date, the Company is implementing new design improvements, which lend to more efficient construction and plant commissioning, are currently being updated and incorporated. The Group has expanded the in house engineering design team to include drafting, electrical design and programmable logic controller programing and site project management. The Group remains focused on bringing its WET® IOsorb™ IO#3, IO#4, IO#5 and IO#6 plants into production. The delivery of the Group's WET® IOsorb™ IO#3 plant ("IO#3") is expected by the end of March 2013. The final construction of IO#3 is being carefully planned to target the most optimal brine streams available which will lead to higher overall production of iodine in 2013 and beyond.

 

 

Commenting on the update, Lance Baller, CEO and President, stated:

"We are excited about our WET®IOsorb ™ and the opportunity they afford to the Group. Iofina remains focused on becoming a world leader in the production of Iodine and Iodine derivatives and the Board looks forward to what it anticipates to be a fourth consecutive year of record revenues in 2013."

 

For further information, please contact:

 

Lance Baller, CEO

Iofina plc

Tel: +44(0)20 3006 3135

 www.iofina.com

 

Ben Colegrave/Chris Sim/Neil Elliot

Investec

Tel: +44(0)20 7597 5970

 

Media Contact:

Dominic Barretto/Anna Legge

Yellow Jersey PR Limited

Tel: +44(0) 7768 537 739 

 

 

 

About Iofina

Iofina specialises in the exploration and production of iodine, iodine specialty chemical derivatives, produced water and natural gas. Iofina's business strategy is to identify, develop, build, own and operate iodine extraction plants currently focused in North America based on Iofina's WET® IOsorb™ technology. Iofina has iodine production operations in the United States, specifically in Texas, California, Montana, Oklahoma and Wyoming. The Group has complete vertical integration from the production of iodine in the field to the manufacture of the chemical end products derived from iodine to the consumer and the recycling of iodine using iodinated side-streams from waste chemical processes in Europe, North America and Asia. The Group utilises its portfolio of patented and patent pending technology, proprietary methods and trademarks throughout all business lines.

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUGUMUWUPWGBQ
Date   Source Headline
2nd May 20247:00 amRNSFinal Results
16th Apr 20247:00 amRNSQ1 2024 Corporate Update
17th Jan 20247:00 amRNSHolding(s) in Company
15th Jan 20247:00 amRNSQ4 2023 Corporate Update
30th Nov 20237:00 amRNSIO#9 Update
20th Oct 20237:00 amRNSSigned Agreement for IO#10 and Q3 2023 Update
11th Sep 20237:00 amRNSInterim Results
25th Aug 20235:00 pmRNSHolding(s) in Company
24th Jul 20235:00 pmRNSHolding(s) in Company
20th Jul 20237:00 amRNSH1 Update and Updated Loan Facilities
14th Jun 20232:00 pmRNSResult of AGM
14th Jun 20237:00 amRNSIO#9 Iodine Plant Operating
9th May 20237:00 amRNSNotice of AGM
4th May 20237:00 amRNSInvestor Presentation
28th Apr 20234:45 pmRNSHolding(s) in Company
28th Apr 20237:00 amRNSGrant of Share Options
25th Apr 20237:00 amRNS2022 FULL YEAR RESULTS
12th Apr 20237:00 amRNSProduction Update
20th Feb 20237:00 amRNSDirector/PDMR Shareholding
6th Feb 20237:00 amRNSTrading Update
9th Jan 20237:00 amRNSMarket Update
28th Dec 20222:34 pmRNSHolding(s) in Company
14th Dec 20227:00 amRNSIofina Chemical Awarded ISO Certification
21st Nov 20227:00 amRNSChange of Adviser
28th Oct 20227:00 amRNSFinalised Terms for IO9 & Q3 Production Update
26th Sep 202211:06 amRNSSecond Price Monitoring Extn
26th Sep 202211:00 amRNSPrice Monitoring Extension
26th Sep 20227:00 amRNSInterim Results
8th Jul 20227:00 amRNSAdditional Loan Facilities and H1 Update
5th Jul 20228:54 amRNSHolding(s) in Company
22nd Jun 20222:30 pmRNSResult of AGM
20th Jun 20227:00 amRNSAppointment of Chrystal Capital Partners LLP
27th May 20227:00 amRNSNotice of AGM
26th May 20224:15 pmRNSHolding(s) in Company
26th May 20222:15 pmRNSHolding(s) in Company
24th May 20226:15 pmRNSHolding(s) in Company
20th May 20227:10 amRNSInvestor Presentation
18th May 20227:00 amRNSHolding(s) in Company
9th May 20227:00 amRNSFinal Results
5th May 20227:00 amRNSHolding(s) in Company
28th Apr 20228:38 amRNSHolding(s) in Company
19th Apr 20227:00 amRNSQ1 2022 and IO#9 Update
8th Apr 20221:07 pmRNSHolding(s) in Company
17th Mar 20227:00 amRNSDirector/PDMR Shareholding
16th Mar 20227:00 amRNSHolding(s) in Company
14th Mar 20227:00 amRNSDirector/PDMR Shareholding
11th Mar 20227:00 amRNSDirector/PDMR Shareholding
10th Mar 20227:00 amRNSDirector/PDMR Shareholding
9th Mar 20227:00 amRNSGrant of Share Options
8th Mar 20228:51 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.